Newsletter | April 5, 2024

Best of March: Top 5 Insights in Drug Formulation and Delivery

Drug Delivery Leader

TOP 5 INSIGHTS IN DRUG FORMULATION AND DELIVERY 

MARCH EDITION

#1 - Tracking 4 Payload Trends In Drug Delivery Development

Amid new research and development in nanocarriers, market attention has shifted toward payloads and enhancing compatibility.This discussion explores the latest trends and includes a research database.

#2 - Selecting Drug Delivery Systems For Higher Doses, Higher Viscosities, And Lower Risk

Discover how companies can de-risk their device selection as they bring this new generation of high-volume, high-viscosity biologics to market.

#3 - Osmotic Controlled Release Oral Drug Delivery: A Closer Look

This article shares the mechanisms of the elements of oral dosage, including the semi-permeable membrane, pore-forming agents, and more, as well as advantages and applications of this type of drug delivery.

#4 - Nanoforming - The Patient- And Planet-Centric Approach From Increasing Bioavailability To Enabling Sustained Drug Delivery

By reducing the size of drug particles, nanoforming can open up new opportunities – from increasing bioavailability to enabling sustained drug delivery. Discover the potential benefits supported by case studies.

#5 - New FDA QMSR Through The Lens Of Risk Management: Requirements And Analysis

The new Quality Management System Regulation (QMSR) is a forward step that is scheduled to be fully implemented by Feb. 2, 2026. Let's take a closer look, including the role of ISO 13485, expectations for compliance with ISO 14971, and more.